Birdshot retinochoroidopathy: pathophysiology, diagnosis and treatment

References

• Shah KH, Levinson RD, Yu F, et al. Birdshot chorioretinopathy. Surv Ophthalmol. 2005;50(6):519–541.
   Google Scholar
• Gasch AT, Smith JA, Whitcup SM. Birdshot retinochoroidopathy. Br. J Ophthalmol. 1999;83(2):241–249.
   Google Scholar
• Thorne JE, Jabs DA, Peters GB, et al. Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol. 2005 Jul;140(1):45–51.
   Google Scholar
• Monnet D, Brezin AP, Holland GN, et al. Longitudinal cohort study of patients with birdshot chorioretinopathy. Am J Ophthalmol. 2006;141(1):135–142.
   Google Scholar
• Knezevic A, Munk MR, Pappas F, et al. HLA-A29 positive birdshot chorioretinopathy in an African American patient. Retin Cases Brief Rep. 2016 Summer;10(3):201–204.
   Google Scholar
• Vitale AT. Birdshot retinochoroidopathy. J Ophthalmic Vis Res. 2014 Jul-Sep;9(3):350–361.
   Google Scholar
• Kuiper JJ, Rothova A, Schellekens PA, et al. Detection of choroid- and retina-antigen reactive CD8(+) and CD4(+) T lymphocytes in the vitreous fluid of patients with birdshot chorioretinopathy. Hum Immunol. 2014 Jun;75(6):570–577.
   Google Scholar
• Dagur PK, Biancotto A, Stansky E, et al. Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM). Clin Immunol. 2014 May-Jun;152(1–2):36–47.
   Google Scholar
• Daien V, Mura F, Martin G, et al. Th17 and regulatory T cells are increased in blood of patients with birdshot chorioretinopathy. Acta Ophthalmol. 2016 Mar:24. DOI:10.1111/aos.12949
   Google Scholar
• Kuiper J, Rothova A, De Boer J, et al. The immunopathogenesis of birdshot chorioretinopathy; a bird of many feathers. Prog Retin Eye Res. 2015 Jan;44:99–110.
   Google Scholar
• Kuiper JJ, Mutis T, De Jager W, et al. Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29-associated birdshot chorioretinopathy. Am J Ophthalmol. 2011;152:177–182.
   Google Scholar
• Yang P, Foster CS. Interleukin 21, interleukin 23, and transforming growth factor b1 in HLA-A29-associated birdshot retinochoroidopathy. Am Journ of Ophthal. 2013;156(2):400.
   Google Scholar
• Brézin AP1, Monnet D, Cohen JH, et al. HLA-A29 and birdshot chorioretinopathy. Ocul Immunol Inflamm. 2011 Dec;19(6):397–400.
   Google Scholar
• Márquez A, Cordero-Coma M, Martín-Villa JM, et al. New insights into the genetic component of non-infectious uveitis through an immunochip strategy. J Med Genet. 2017 Jan;54(1):38–46.
   Google Scholar
• Kuiper JJ, Van Setten J, Ripke S, et al. A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy. Hum Mol Genet. 2014 Nov 15;23(22):6081–6087.
   Google Scholar
• Zamecki KJ, Jabs DA. HLA typing in uveitis: use and misuse. Am Ophthalmol. 2010;149(2):189–193.
   Google Scholar
• Lopez de Castro JA, Alvarez-Navarro C, Brito A, et al. Molecular and pathogenic effects of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in MHC-I-associated inflammatory disorders: towards a unifying view. Mol Immunol. 2016;77:193–204.
   Google Scholar
• Nussenblatt RB, Mittal KK, Ryan S, et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol. 1982;94:147–158.
   Google Scholar
• Touhami S, Fardeau C, Vanier A, et al. Birdshot retinochoroidopathy: prognostic factors of long-term visual outcome. Am J Ophthalmol. 2016 Oct;170:190–196.
   Google Scholar
• Silpa-Archa S, Cao JH, Boonsopon S, et al. Birdshot retinochoroidopathy: differences in clinical characteristics between patients with early and late age of onset. Ocul Immunol Inflamm. 2016;12:1–7.
   Google Scholar
• Pulido JS, Canal I, Salomão D, et al. Histological findings of birdshot chorioretinopathy in an eye with ciliochoroidal melanoma. Eye (Lond). 2012 Jun;26(6):862–865.
   Google Scholar
• Gaudio PA, Kaye DB, Crawford JB. Histopathology of birdshot retinochoroidopathy. Br J Ophthalmol. 2002;86(12):1439–1441.
   Google Scholar
• Sohn EH, Chirco KR, Folk JC, et al. Clinicopathological correlation in a patient with previously treated birdshot chorioretinopathy. Retin Cases Brief Rep. 2016 Jul 26. [Epub ahead of print].
   Google Scholar
• Jack LS, Agarwal A, Sepah YJ, et al. Spatial agreement between Goldmann visual field defects and fundus autofluorescence in patients with birdshot chorioretinopathy. J Ophthalmic Inflamm Infect. 2016 Dec;6(1):18.
   Google Scholar
• Gallagher MJ, Yilmaz T, Cerbantes-Castaneda RA, et al. The characteristics features of optical coherence tomography in posterior uveitis. Br J Ophthalmol. 2007;91(12):1680–1685.
   Google Scholar
• Monnet D, Levinson RD, Holland GN, et al. Longitudinal cohort study of patients with birdshot chorioretinopathy. III. Macular imaging at baseline. Am J Ophthalmol. 2007;144(6):818–828.
   Google Scholar
• Birnbaum AD, Fawzi AA, Rademaker A, et al. Correlation between clinical signs and optical coherence tomography with enhanced depth imaging findings in patients with birdshot chorioretinopathy. JAMA Ophthalmol. 2014 Aug;132(8):929–935.
   Google Scholar
• Teussink MM, Huis In Het Veld PI, De Vries LA, et al. Multimodal imaging of the disease progression of birdshot chorioretinopathy. Acta Ophthalmol. 2016 Dec;94(8):815–823.
   Google Scholar
• Phasukkijwatana N, Lafe N, Sarraf D. Optical coherence tomography angiography of A29 birdshot chorioretinopathy complicated by retinal neovascularization. Retin Cases Brief Rep. 2017 Winter;11(Suppl 1):S68–S72.
   Google Scholar
• Shantha JG, Ho VY, Patel P, et al. Choroidal neovascularization associated with birdshot chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2016 May 1;47(5):450–457.
   Google Scholar
• Birch DG, Williams PD, Callanan D, et al. Macular atrophy in birdshot retinochoroidopathy: an optical coherence tomography and multifocal electroretinography analysis. Retina. 2010;30(6):930–937.
   Google Scholar
• Young M, Fallah N, Forooghian F. Choroidal degeneration in birdshot chorioretinopathy. Retina. 2015 Apr;35(4):798–802.
   Google Scholar
• deCarlo TE, Bonini Filho MA, Adhi M, et al. Retinal and choroidal vasculature in birdshot chorioretinopathy analyzed using spectral domain optical coherence tomography angiography. Retina. 2015 Nov;35(11):2392–2399.
   Google Scholar
• Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol. 1980;89(1):31–45.
   Google Scholar
• Levinson RD, Brezin A, Rothova A, et al. Research criteria for the diagnosis of birdshot chorioretinopathy: results of a international consensus conference. Am J Ophthalmol. 2006;141(1):185–187.
   Google Scholar
• Touhami S, Fardeau C, Vanier A, et al. Visual acuity in birdshot retinochoroidopathy evaluation. Am J Ophthalmol. 2015 Oct;160(4):817–821.
   Google Scholar
• Willermain F, Greiner K, Forrester JV. Atypical end-stage birdshot retinochoroidopathy. Ocul Immunol Inflamm. 2003;11(4):305–307.
   Google Scholar
• Read RW, Rao NA. Sharma OP: sarcoid choroiditis initially diagnosed as birdshot choroidopathy. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17:85–86.
   Google Scholar
• Boni C, Thorne JE, Spaide RF, et al. Choroidal findings in eyes with birdshot chorioretinitis using enhanced-depth optical coherence tomography. Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT591-9. doi: 10.1167/iovs.15-18832.
   Google Scholar
• Amalric P, Cuq G. Une forme très particulière de choriorétinopathie en grains de riz. Bull Soc Ophthalmol Fr. 1981;81:131–134.
   Google Scholar
• Fardeau C, Herbort CP, Kullmann N, et al. Indocyanine green angiography in birdshot chorioretinopathy. Ophthalmology. 1999;106:1928–1934.
   Google Scholar
• Reddy AK, Gonzalez MA, Henry CR, et al. Diagnostic sensitivity of indocyanine green angiography for birdshot chorioretinopathy. JAMA Ophthalmol. 2015;133(7):840–843. doi:10.1001/jamaophthalmol.2015.0822.
   Google Scholar
• Herbort CP, Borruat FX, deCourten C, et al. Indocyanine green angiography in posterior uveitis. Klin. Monbl Augenheilkd. 1996;208(5):321–326.
   Google Scholar
• Howe LJ, Stanford MR, Graham EM, et al. Choroidal abnormalities I birdshot chorioretinopathy: an indocyanine green angiography study. Eye. 1997;11:554–559.
   Google Scholar
• Herbort CP, Probst K, Cimino L, et al. Differential inflammatory involvement in retina and choroid in birdshot chorioretinopathy. Klin Monbl Augenheilkd. 2004;221(5):351–356.
   Google Scholar
• Symes R, Young M, Forooghian F. Quantitative assessment of retinal degeneration in birdshot chorioretinopathy using optical coherence tomography. Ophthalmic Surg Lasers Imaging Retina. 2015 Nov–Dec;46(10):1009–1012.
   Google Scholar
• Schmitz-Valckenberg S, Holz FG, Bird AC, et al. Fundus autofluorescence imaging: review and perspectives. Retina. 2008;28(3):385–409.
   Google Scholar
• Koizumi H, Pozzoni MC, Spaide RF. Fundus autofluorescence in birdshot chorioretinopathy. ophthalmology. 2008;115(5):15–20.
   Google Scholar
• Yeh S, Forooghian F, Wong WT, et al. Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol. 2010;128(1):46–56.
   Google Scholar
• Giuliari G, Hinkle DM, Foster CS. The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. J Ophthalmol. 2009;2009:1–5.
   Google Scholar
• Renfro L1, Snow JS. Ocular effects of topical and systemic steroids. Dermatol Clin. 1992 Jul;10(3):505–512.
   Google Scholar
• Sen HM, Vitale S, Gangaputra SS, et al. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology. 2014;121:2275–2286.
   Google Scholar
• Kiss S, Ahmed M, Letko E, et al. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology. 2005;112(6):1066–1071.
   Google Scholar
• Rothova A, Berendschot TT, Probst K, et al. Birdshot chorioretinopathy: longterm manifestations and visual prognosis. Ophthalmology. 2004;111(5):954–959.
   Google Scholar
• Hafidi M, Loria O, Kodjikian L, et al. Efficacy of methylprednisolone pulse followed by oral prednisone in birdshot chorioretinopathy. Ocul Immunol Inflamm. 2016;5:1–8.
   Google Scholar
• Gobuty M, Adhi M, Read SP, et al. Visual response and anatomical changes on sequential spectral-domain optical coherence tomography in birdshot chorioretinopathy treated with local corticosteroid therapy. Int J Retina Vitreous. 2016 Feb;20(2):9.
   Google Scholar
• Siddique SS, Shah R, Suelves AM, et al. Road to remission: a comprehensive review of therapy in uveitis. Expert Opin Investig Drugs. 2011;20:1497–1515.
   Google Scholar
• Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Oophthalmol. 2010;149:423–432.
   Google Scholar
• Kacmaz RO, Kampen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010;117:576–584.
   Google Scholar
• Gangaputra S, Newcomb CW, Liesegang TL, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116:2188–2198.
   Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513.
   Google Scholar
• Pasadhika S, Kempen JH, Newcomb CW, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009;148:500–509.
   Google Scholar
• Freitas-Neto CA, Boonsopon S, Dhanireddy S, et al. Birdshot retinochoroidopathy review. Arq Bras Oftalmol. 2015 Jan–Feb;78(1):56–61.
   Google Scholar
• Heo J, Sepah YJ, Yohannan J, et al. The role of biologic agents in the management of non-infectious uveitis. Expert Opin Biol Ther. 2012;12:995–1008.
   Google Scholar
• Gonzalez-Lopez JJ, Ciancas E, Revenga M. Recommendations for the management of birdshot retinochoroiditis. Arch Soc Esp Oftalmol. 2016 May 17;S0365-6691(16):30024–30027.
   Google Scholar
• Mollins B, Mesquida M, Llorenç V, et al. Elevated serum immune mediators and subclinical inflammation in hla-a29-associated birdshot chorioretinopathy. Ocul Immunol Inflamm. 2016 Dec;24(6):647–652.
   Google Scholar
• Vitale AT, Rodriguez A, Foster CS. Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy. Ophthalmology. 1994;101(5):822–831.
   Google Scholar
• Zacks DN, Samson CM, Loewenstein J, et al. Electroretinograms as an indicator of disease activity in birdshot retinochroidopathy. Graefes Arch Cli Exp Ophthalmol. 2002;240(8):601–607.
   Google Scholar
• Tzekov R, Madow B. Visual electrodiagnostic testing in birdshot chorioretinopathy. J Ophthalmol. 2015;2015:1–9.
   Google Scholar
• Audo I, Robson AG, Holder GE, et al. The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction. Surv Ophthalmol. 2008;53(1):16–40.
   Google Scholar
• Sobrin L, Lam BL, Liu M, et al. Electroretinographic monitoring in birdshot chorioretinopathy. Am J Ophthalmol. 2005;140(1):52–64.
   Google Scholar
• Thorne JE, Jabs DA, Kedhar SR, et al. Loss of visual field among patients with birdshot chorioretinopahty. Am J Oophthalmol. 2008;145(1):23–28.
   Google Scholar
• Gordon LK, Goldhardt R, Holland GN, et al. Standardized visual field assessment for patients with birdshot chorioretinopathy. Ocul Immunol Inflamm. 2006;14(6):325–332.
   Google Scholar
• Giuliari G, Pujari S, Shaikh M, et al. Microperimetry and birdshot chorioretinopathy. Can J Ophthalmol. 2010;45(4):399–403.
   Google Scholar
• Silpa-Archa S, Lee JJ, Boonsopon S, et al. Poor prognostic factors in patients with birdshot retinochoroidopathy. Retina. 2016 Nov;36(11):2220–2226.
   Google Scholar
• Maleki A, Swan RT, Silpa-Archa S, et al. Short-wavelength automated perimetry parameters at baseline and following remission in patients with birdshot retinochoroidopathy. Am J Ophthalmol. 2016;163:83–92.
   Google Scholar
• Spry PG, Johnson CA, Mansberger SL, et al. Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma. 2005;14(1):11–19.
   Google Scholar
• Arya B, Westcott M, Robson AG, et al. Pointwise linear regression analysis of serial Humphrey visual fields and a correlation with electroretinography in birdshot chorioretinopathy. Br J Ophthalmol. 2015 Jul;99(7):973–978.
   Google Scholar
• Agrawal R, Joachim N, Li LJ, et al. Assessment of retinal vascular calibres as a biomarker of disease activity in birdshot chorioretinopathy. Acta Ophthalmol. 2017 Mar;95(2):e113-e118. doi: 10.1111/aos.13156. Epub 2016 Aug 6.
   Google Scholar
• Cao JH, Silpa-Archa S, Freitas-Neto CA, et al. Birdshot chorioretinitis lesions on indocyanine green angiography as an indicator of disease activity. Retina. 2016 Sep;36(9):1751–1757.
   Google Scholar
• Silpa-Archa, Maleki A, Roohipoor R, et al. Analysis of 3-D choroidal volume with enhanced depth imaging findings in patients with birdshot retinochoroidopathy. Retina. 2016 Sep;36(9):1758–1766.
   Google Scholar
• Levy-Clark G, Jabs DA, Read RW, et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121:785–796.
   Google Scholar
• Pasadhika S, Suhler E, Cunningham E. Use of biologic agents in the treatment of uveitis. Rev Ophthalmol. 2010;10:3.
   Google Scholar
• Sobrin L, Huang J, Christen W, et al. Daclizumab for treatment of birdshot chorioretinopathy. Arch Ophthalmol. 2008;126(2):186–191.
   Google Scholar
• Dastiridou A, Kalogeropoulos C, Brazitikos P, et al. New biologic-response modifiers in ocular inflammatory disease: beyond anti-TNF treatment. Expert Rev Clin Pharmacol. 2012;5:543–555.
   Google Scholar
• Artornsombudh P, Gevorgyan O, Payal A, et al. Infliximab treatment of patients with birdshot retinochoroidopathy. Ophthalmology. 2013;120(3):588–592.
   Google Scholar
• Calvo-Rio V, Blanco R, Santos-Gómez M, et al. Efficacy of anti-IL6-receptor tocilizumab in refractory cystoid macular edema of birdshot retinochoroidopathy report of two cases and literature review. Ocul Immunol Inflamm. 2016 Oct 11;1–6. [Epub ahead of print].
   Google Scholar
• Papo M, Bielefeld P, Vallet H, et al. Tocilizumab in severe and refractory non-infectious uveitis. Clin Exp Rheumatol. 2014 Jul–Aug;32(4 Suppl 84):S75–9.
   Google Scholar
• Kempen JH, Gangaputra S, Daniel E, et al. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol. 2008;146:802–812.
   Google Scholar
• Rivera De Zea P, García-Ben A, Rachwani Parshotam N, et al. Dexamethasone intravitreal implant for treatment of persistent macular oedema in birdshot retinochoroidopathy. Arch Soc Esp Oftalmol. 2016 Mar;91(3):138–141.
   Google Scholar
• Friedman DS, Holbrook JT, Ansari H, et al. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology. 2013;120:1571–1579.
   Google Scholar
• Moisseiev E, Moshiri A. Ozurdex for the treatment of a patient with birdshot chorioretinopathy. Case Rep Ophthalmol. 2015 Sep 3;6(3):289–292.
   Google Scholar
• Bajwa A, Aziz K. Fluocinolone acetonide intravitreal implant (0.59mg) in birdshot retinochoroidopathy. Retina. 2014;34(11):2259–2268.
   Google Scholar
• Walsh J, Reddy AK. Intravitreal dexamethasone implantation for birdshot chorioretinopathy. Retin Cases Brief Rep. 2017 Winter;11(1):51–55.
   Google Scholar
• Sen HN, Bodaghi B, Hoang PL, et al. Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm. 2009;17(3):133–141.
   Google Scholar